The University of Chicago Header Logo

Connection

Kourosh Rezania to Double-Blind Method

Back to Details
This is a "connection" page, showing publications Kourosh Rezania has written about Double-Blind Method.
Kourosh Rezania
Connection Strength
0.077
Double-Blind Method
  1. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2021 05; 22(3-4):287-299.
    View in: PubMed
    Score: 0.035
  2. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009 Aug; 66(2):235-44.
    View in: PubMed
    Score: 0.016
  3. Terbutaline in myasthenia gravis: a pilot study. J Neurol Sci. 2009 Feb 15; 277(1-2):150-4.
    View in: PubMed
    Score: 0.015
  4. A clinical trial of creatine in ALS. Neurology. 2004 Nov 09; 63(9):1656-61.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.